Clinical Trial Update: Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement [Phase 3]

View source ↗

Summary

Phase 3 study evaluating emerging treatments to prevent infection in total joint replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Joint Infection

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Periprosthetic Joint Infection, Draining Wound | Phase 3 | Status: COMPLETED